Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer

BACKGROUND: There are many molecular differences between estrogen receptor α (ERα)-positive and ER-negative breast cancers. Recent analyses have shown that the former can be divided into two subtypes, luminal A and luminal B. These differ in response to endocrine therapy and chemotherapy, and in pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Endo, Yumi, Yamashita, Hiroko, Takahashi, Satoru, Sato, Shinya, Yoshimoto, Nobuyasu, Asano, Tomoko, Hato, Yukari, Dong, Yu, Fujii, Yoshitaka, Toyama, Tatsuya
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364092/
https://ncbi.nlm.nih.gov/pubmed/25528056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-990
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados